Apollo Hospitals (Q1 FY13)

India Infoline News Service | Mumbai |

Consolidated PAT grew 44.2% to Rs787mn in Q1 FY13.

CMP Rs614, Target Rs732, Upside 19.2% 
  • Consolidated revenue grew by 21.8% yoy driven by strong growth in retail pharmacy (+31%) and hospitals biz (+17%). Standalone Revenues recorded growth of 21.3% yoy to Rs.7.7bn.

  • Chennai cluster recorded improved performance (+19.4% yoy to Rs2.5bn) led by strong ARPOB growth on the back of better case mix and pricing. Hyderabad clusters’ revenues grew by 14.5% yoy to Rs976mn. Other Hospitals outside of Chennai & Hyderabad (Utilisation: Bhubaneshwer- 70%, Madurai-86%, Mysore-73%) also displayed strong growth. Overall owned bed occupancy was 74% in Q1 FY13.

  • Apollo Munich achieved a gross written premium of Rs.1bn in Q1 FY13 representing a growth of 42% yoy. Similarly, the earned premium demonstrated traction expanding 59.6% to Rs1,080mn. The claim loss ratio has been sustained at 58% even in this quarter.

  • Consolidated EBITDA margin expanded by 29 bps yoy to 16.8% aided by expansion in Healthcare services EBITDA (+20bps to 19%), improved EBITDA contribution by SAPs and reduction in negative EBITDA in Apollo Munich health insurance. Also, Standalone pharmacies continue its EBITDA expansion trajectory (+130 bps yoy to 1.5%) on the back of buying efficiencies and operating leverage creeping in. Standalone EBITDA grew by 22.6% yoy to Rs1304mn resulting in the same reported EBITDA margin of 16.8% as of consolidated.

  • Consolidated PAT grew 44.2% to Rs787mn in Q1 FY13. Standalone PAT grew by 36% yoy to Rs697mn. Lower taxes on account of effective tax rate lower at c27% for next few years (benefits under section 35AD (8)(c) of Income tax) led better than expected growth in PAT.

Operating matrix
Particulars (Rs mn) Q1FY13 Q1FY12 %yoy Q4FY12 % qoq
Segment Revenue        
Healthcare Services 5,299 4,514 17.4 5,070 4.5
Pharmacy 2,477 1,898 30.5 2,377 4.2
Others 41 47 (12.5) 65 (37.0)
Less: Inter-segmental Revenue 2 2 - 2 -
Total 7,815 6,457 21 7,510 4
Profit before Tax and Interest          
Healthcare Services 1,015 856 18.5 923 9.9
Pharmacy 38 3 1,206.9 36 4.4
Others 41 47 (12.5) 65 (37.0)
Less: Interest 137 147 (6.8) 155 (11.7)
Less: Other Unallocable Exp - -   -  
PBT 957 759 26 869 10
Capital Employed          
Healthcare Services 24,201 20,379 18.8 22,521 7.5
Pharmacy 2,843 2,249 26.4 2,716 4.7
Others 3,566 2,894 23.2 4,457 (20.0)
Total 30,610 25,522 19.9 29,693 3.1
 
Result Table (Standalone)
Quarterly -(Rs. in Mn.) Q1FY13 Q1FY12 %yoy Q4FY12 % qoq
Net Sales   7,774   6,410   21.3   7,446   4.4
(Inc)/Decrese in stock   (218)   (103)   110.9   (65)   236.8
Material consumption   (2,230)   (1,968)   13.4   (2,033)
BSE 1,198.20 [6.95] ([0.58]%)
NSE 1,198.10 [8.80] ([0.73]%)

***Note: This is a NSE Chart

 

Advertisements

  • Save upto Rs.2.67 lakh with Pradhan Mantri Awas Yojana ...Know more
  • Now Save Rs.3150 on your Demat Account ...Click here
  • Now get IIFL Personal Loan in just 8* hours...APPLY NOW!
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.